Latest Cost Reduction News

Hydralyte USA reports its best EBITDA performance since IPO, driven by strong sales and cost reductions, setting the stage for growth with upcoming product launches.

Perpetual Limited has successfully refinanced its syndicated debt facilities with improved terms, pushing out maturities and lowering its gross debt forecast for FY25.

Wingara AG Limited reported an 18% revenue increase to $3.5 million for FY25 but posted a reduced net loss of $1.47 million, reflecting a strategic pause in fodder operations amid challenging market conditions.

Cann Group Limited has reported a strong operational update, exceeding its medicinal cannabis production targets and significantly reducing costs, while expanding sales channels and securing fresh capital to bolster its balance sheet.

Eden Innovations reports a significant surge in EdenCrete® product sales, led by the rapid adoption of EdenCrete® Pz7 across the US, Ecuador, Mexico, and Canada. Sales for April-May 2025 alone outpaced the previous year’s quarter by 86%, signaling strong market momentum.

Select Harvests Limited has reported a remarkable turnaround with a $28.7 million net profit for the half-year ended March 2025, driven by higher almond prices and operational gains. The company forecasts a solid 2025 crop and has renewed a $240 million syndicated debt facility.

Develop has initiated significant underground and surface infrastructure works at its Sulphur Springs zinc-copper project in Western Australia, setting the stage for an updated feasibility study and de-risking the project’s development.

Myer Holdings has unveiled a comprehensive strategic transformation plan, integrating its recent Apparel Brands acquisition and leveraging a strengthened balance sheet to drive sustained earnings growth. The company aims to redefine its retail presence through customer-centric innovation and operational efficiency.

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.

Straker Ltd has reported a record adjusted EBITDA of NZ$4.8 million for FY25, driven by strong growth in AI subscription services and operational efficiencies, even as overall revenue declined 10.3%. The company’s strategic pivot towards AI-powered offerings signals a promising shift in its business model.

Metro Performance Glass reported a net loss for FY25 amid market softness but outlines a clear recovery plan with leadership changes and an equity raise to strengthen its position.

Credit Clear Limited confirms it remains on track to meet its FY25 earnings guidance, buoyed by strong client growth and cost-cutting measures, even as revenue forecasts are revised downward due to timing delays.